BridgeMD
New treatment option for Melanoma (Skin)
Official title Immunological Functionnal Test Validation to Predict Melanoma Metastatic Patient Response to Checkpoint Inhibitors
ClinicalTrials.gov ID: NCT05649683
What this study is testing
What is Evaluation of cytokine production?
Evaluation of cytokine production is an investigational medicine, being studied as a potential treatment for melanoma (skin).
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Checkpoint inhibitor such as anti-CTLA-4 and anti-PD-1 are known to block inhibitory signals and increase the immune antimutoral response. Nivolumab and Ipilimumab association is considered as a more efficient immunotherapy to treat advanced melanoma.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Inclusion
- persone of major age,
- advanced melanoma confirmed,
- RECIST 1.1 disease,
- first line treatment
You likely can't join if
- occular and mucosal melanoma,
- previous checkpoint inhibitor treatment,
- active brain metastasis,
- concomitant immunosuppressive treatment
The study team makes the final eligibility decision.
Where it's taking place
- Nice, Alpes-maritimes, France
- Montpellier, Occitanie, France
- Lille, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nice, Alpes-maritimes, France; Montpellier, Occitanie, France; Lille, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.